Concepedia

Gabriel Gallo-Oller

GG

Statistics

Publications

10

Citations

435

H-Index

10

Active since

2016

Affiliations

Karolinska Institutet(Current)

Universitat Autònoma de Barcelona

Vall d'Hebron Institut de Recerca

University of Gothenburg

Massachusetts General Hospital

Gabriel Gallo-Oller is an author at Karolinska Institutet specializing in molecular oncology, oncology, and malignant neoplasms.

ORCID

Publications per year

2016–2022

10

Publications

10

A new background subtraction method for Western blot densitometry band quantification through image analysis software

Gabriel Gallo-Oller, Raquel Ordóñez, Javier Dotor · Journal of Immunological Methods · 2018 · 202 citations

, , +6

Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma

Øyvind H. Hald, Lotte Olsen, Gabriel Gallo-Oller et al. · Oncogene · 2018 · 72 citations · Full text

, , +17

P144, a Transforming Growth Factor beta inhibitor peptide, generates antitumoral effects and modifies SMAD7 and SKI levels in human glioblastoma cell lines

Gabriel Gallo-Oller, Arabel Vollmann‐Zwerenz, Bárbara Meléndez et al. · Cancer Letters · 2016 · 28 citations

, , +16

miRNA-7 and miRNA-324-5p regulate alpha9-Integrin expression and exert anti-oncogenic effects in rhabdomyosarcoma

Carla Molist, Natalia Navarro, Irina Giralt et al. · Cancer Letters · 2020 · 28 citations

, , +13

Establishment and characterization of an orthotopic patient-derived Group 3 medulloblastoma model for preclinical drug evaluation

Emma Sandén, Cecilia Dyberg, Cecilia Krona et al. · Scientific Reports · 2017 · 25 citations · Full text

, , +10

1–5 of 10